BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35473671)

  • 21. Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis.
    Xu Y; Jia Y; Zhang Q; Du Y; He Y; Zheng A
    Gynecol Oncol; 2021 Feb; 160(2):610-618. PubMed ID: 33221022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial ovarian cancers and endometriosis.
    Acién P; Velasco I; Acién M; Capello C; Vela P
    Gynecol Obstet Invest; 2015; 79(2):126-35. PubMed ID: 25634648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Social support and ovarian cancer incidence - A Swedish prospective population-based study.
    Idahl A; Hermansson A; Lalos A
    Gynecol Oncol; 2018 May; 149(2):324-328. PubMed ID: 29555331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical characteristics of borderline ovarian tumors and stage I epithelial ovarian cancer: an analysis of 143 cases].
    Zhao Y; Wang Y; Shen Dh; Song Rn; Xu Q; Li Y; Cui H; Tang J; Wei Lh
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 43(1):123-8. PubMed ID: 21321635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study.
    Tung KH; Goodman MT; Wu AH; McDuffie K; Wilkens LR; Kolonel LN; Nomura AM; Terada KY; Carney ME; Sobin LH
    Am J Epidemiol; 2003 Oct; 158(7):629-38. PubMed ID: 14507598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES).
    Schildkraut JM; Abbott SE; Alberg AJ; Bandera EV; Barnholtz-Sloan JS; Bondy ML; Cote ML; Funkhouser E; Peres LC; Peters ES; Schwartz AG; Terry P; Crankshaw S; Camacho F; Wang F; Moorman PG
    Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1411-1417. PubMed ID: 27197282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
    Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
    Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovulation and risk of epithelial ovarian cancer.
    Purdie DM; Bain CJ; Siskind V; Webb PM; Green AC
    Int J Cancer; 2003 Mar; 104(2):228-32. PubMed ID: 12569579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis.
    Suri A; Perumal V; Ammalli P; Suryan V; Bansal SK
    Sci Rep; 2021 Aug; 11(1):17308. PubMed ID: 34453074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.
    Yang Z; Gu JH; Guo CS; Li XH; Yang WC
    Oncotarget; 2017 Jul; 8(28):46414-46424. PubMed ID: 28423365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes.
    Mortlock S; Corona RI; Kho PF; Pharoah P; Seo JH; Freedman ML; Gayther SA; Siedhoff MT; Rogers PAW; Leuchter R; Walsh CS; Cass I; Karlan BY; Rimel BJ; ; Montgomery GW; Lawrenson K; Kar SP
    Cell Rep Med; 2022 Mar; 3(3):100542. PubMed ID: 35492879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of ovulation IGF and HGF signaling on the oncogenesis of murine epithelial ovarian cancer cell ID8.
    Chu TY; Chu SC; Khine AA; Chen PC; Lee MH; Huang HS
    Exp Cell Res; 2022 Oct; 419(2):113323. PubMed ID: 36030968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of obesity on survival of women with epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.
    Yang HS; Yoon C; Myung SK; Park SM
    Int J Gynecol Cancer; 2011 Dec; 21(9):1525-32. PubMed ID: 22080892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of in vitro chemoresponse profiles in women with Type I and Type II epithelial ovarian cancers: An observational study ancillary analysis.
    Previs R; Leath CA; Coleman RL; Herzog TJ; Krivak TC; Brower SL; Tian C; Secord AA
    Gynecol Oncol; 2015 Aug; 138(2):267-71. PubMed ID: 26037898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
    Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
    Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
    [No Abstract]   [Full Text] [Related]  

  • 36. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
    Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
    Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for epithelial ovarian tumours of borderline malignancy.
    Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
    Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epithelial ovarian cancer and fertility preservation: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Uzan C; Courbiere B; Chabbert-Buffet N
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):180-186. PubMed ID: 30704956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition.
    Ose J; Fortner RT; Rinaldi S; Schock H; Overvad K; Tjonneland A; Hansen L; Dossus L; Fournier A; Baglietto L; Romieu I; Kuhn E; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Masala G; Sieri S; Tumino R; Sacerdote C; Mattiello A; Ramon Quiros J; Obón-Santacana M; Larrañaga N; Chirlaque MD; Sánchez MJ; Barricarte A; Peeters PH; Bueno-de-Mesquita HB; Onland-Moret NC; Brändstedt J; Lundin E; Idahl A; Weiderpass E; Gram IT; Lund E; Kaw KT; Travis RC; Merritt MA; Gunther MJ; Riboli E; Kaaks R
    Int J Cancer; 2015 Jan; 136(2):399-410. PubMed ID: 24890047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer.
    Mackay HJ; Brady MF; Oza AM; Reuss A; Pujade-Lauraine E; Swart AM; Siddiqui N; Colombo N; Bookman MA; Pfisterer J; du Bois A;
    Int J Gynecol Cancer; 2010 Aug; 20(6):945-52. PubMed ID: 20683400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.